Early Emergence Phase of SARS-CoV-2 Delta Variant in Florida, US
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
SARS-CoV-2, the causative agent of COVID-19, emerged in late 2019. The highly contagious B.1.617.2 (Delta) variant of concern (VOC) was first identified in October 2020 in India and subsequently disseminated worldwide, later becoming the dominant lineage in the US. Understanding the local transmission dynamics of early SARS-CoV-2 introductions may inform actionable mitigation efforts during subsequent pandemic waves. Yet, despite considerable genomic analysis of SARS-CoV-2 in the US, several gaps remain. Here, we explore the early emergence of the Delta variant in Florida, US using phylogenetic analysis of representative Florida and globally sampled genomes. We find multiple independent introductions into Florida primarily from North America and Europe, with a minority originating from Asia. These introductions led to three distinct clades that demonstrated varying relative rates of transmission and possessed five distinct substitutions that were 3–21 times more prevalent in the Florida sample as compared to the global sample. Our results underscore the benefits of routine viral genomic surveillance to monitor epidemic spread and support the need for more comprehensive genomic epidemiology studies of emerging variants. In addition, we provide a model of epidemic spread of newly emerging VOCs that can inform future public health responses.
Article activity feed
-
-
SciScore for 10.1101/2022.02.18.22271195: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources A subsampling strategy was chosen to minimize the unbalanced representation of location-specific data while maximizing the genetic diversity and temporal distribution of sampling times for each geographic location using the Temporal And diveRsity Distribution Sampler for Phylogenetics (TARDiS) [32]. TARDiSsuggested: (TARDIS, RRID:SCR_006322)Manual curation using Aliview was performed to specify start site and remove artifacts at the terminal regions [34]. Aliviewsuggested: (AliView, RRID:SCR_002780)The ML tree was first assessed for the presence of temporal signal by evaluating the linear … SciScore for 10.1101/2022.02.18.22271195: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources A subsampling strategy was chosen to minimize the unbalanced representation of location-specific data while maximizing the genetic diversity and temporal distribution of sampling times for each geographic location using the Temporal And diveRsity Distribution Sampler for Phylogenetics (TARDiS) [32]. TARDiSsuggested: (TARDIS, RRID:SCR_006322)Manual curation using Aliview was performed to specify start site and remove artifacts at the terminal regions [34]. Aliviewsuggested: (AliView, RRID:SCR_002780)The ML tree was first assessed for the presence of temporal signal by evaluating the linear relationship between genetic distance of each tip from the best-fitting root of the tree (rooted on the branch that minimizes the mean square of the residuals) with its respective sampling time using TempEst v1.5.3 [36]. TempEstsuggested: (TempEst, RRID:SCR_017304)Focused Bayesian molecular clock analysis was then conducted on the resulting individual clades using BEAST 1.10.4 [41]. BEASTsuggested: (BEAST, RRID:SCR_010228)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-